XML 13 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]            
Revenues $ 2,374,584 $ 1,386,454 $ 7,686,330 $ 4,423,763 $ 6,804,169 $ 4,038,048
Cost of goods sold 1,557,565 930,518 4,977,255 3,149,598 4,681,691 2,556,130
Gross profit 817,019 455,936 2,709,075 1,274,165 2,122,478 1,481,918
Research and development expenses, net 319,875 121,640 700,605 347,851 505,300 456,377
Selling, general and administrative expenses 962,591 414,475 3,111,397 1,430,880 2,101,610 1,374,160
Business acquisition expenses         128,111 0
Total operating expenses 1,282,466 536,115 3,812,002 1,778,731 2,735,021 1,830,537
Operating loss (465,447) (80,179) (1,102,927) (504,566) (612,543) (348,619)
Interest Income (expense) (683) (304) (138) (1,150) (1,416) (1,859)
Loss before provision for income taxes         (613,959) (350,478)
Provision for income taxes         912 912
Net loss $ (466,130) $ (80,483) $ (1,103,065) $ (505,716) $ (614,871) $ (351,390)
Loss Per Share:            
Basic and diluted $ (0.04) $ (0.01) $ (0.09) $ (0.04) $ (0.05) $ (0.04)
Weighted Average Common Shares Outstanding:            
Basic and diluted 12,982,494 12,020,328 12,898,004 11,294,902 11,486,079 9,826,151